For most patients, reaching goal weight does not signal the end of treatment but rather a transition from the weight loss phase to the weight maintenance phase, which typically requires continued pharmacological support for optimal outcomes as long as benefits outweigh risks
Luzzi S, Papiri G, Viticchi G, Baldinelli S, Fiori C, Silvestrini M, Toraldo A (2021) Association between homocysteine levels and cognitive profile in Alzheimers disease
You might lose 1-2 pounds per week during this phase
GLP1 prevented increases in the atrial effective refractory period, P-wave duration, atrial conduction time, atrial conduction velocities and action potential duration, which were observed in dB/dB mice
Lunati ME, Cimino V, Bernasconi D, et al
Last reviewed April 2026